Sun Pharma Advanced Research Company Limited (SPARC) Share Analysis
NSE · Healthcare · Pharmaceuticals
Sun Pharma Advanced Research Company Limited (NSE: SPARC) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹194.00, market capitalisation ₹6,293 Cr, P/E 3.94, ROE 279%.
Get the AI verdict on SPARC: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
SPARC price and valuation
- Share price
- ₹194.00
- Market cap
- ₹6,293 Cr
- P/E ratio
- 3.94
- P/B ratio
- 4.7
- EPS
- ₹48.81
- Book value per share
- ₹41.30
- Dividend yield
- 0%
SPARC profitability and growth
- ROE
- 279%
- ROCE
- 164%
- Debt to equity
- 0.42
- Revenue growth (3 yr)
- 99%
- Revenue growth (5 yr)
- -
- Profit growth (3 yr)
- 108%
- Profit growth (5 yr)
- -
SPARC 52-week range
- 52-week high
- ₹289.00
- 52-week low
- ₹108.00
- Face value
- ₹1.00
SPARC shareholding pattern
- Promoters
- 65.68%
- FIIs
- 3.9%
- DIIs
- 0.09%
- Public
- 30.34%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.